These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial. Saricicek A; Maloney K; Muralidharan A; Ruf B; Blumberg HP; Sanacora G; Lorberg B; Pittman B; Bhagwagar Z J Clin Psychiatry; 2011 Jun; 72(6):744-50. PubMed ID: 21034692 [TBL] [Abstract][Full Text] [Related]
8. Discrepancy in response and remission rates for SAMe-treated patients in a double-blind, randomized clinical trial. Fleisch SB; Travis MJ; Ryan ND Am J Psychiatry; 2010 Dec; 167(12):1533; author reply 1533. PubMed ID: 21131413 [No Abstract] [Full Text] [Related]
9. [Controlled double-blind study (SAMe-imipramine) in depressive syndromes]. Mantero M; Pastorino P; Carolei A; Agnoli A Minerva Med; 1975 Nov; 66(78):4098-101. PubMed ID: 1103017 [TBL] [Abstract][Full Text] [Related]
10. Comparison between the antidepressant activity and of S-adenosylmethionine (SAMe) and that of some tricyclic drugs. Miccoli L; Porro V; Bertolino A Acta Neurol (Napoli); 1978; 33(3):243-55. PubMed ID: 371351 [No Abstract] [Full Text] [Related]
11. N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial. Berk M; Copolov DL; Dean O; Lu K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Bush AI Biol Psychiatry; 2008 Sep; 64(6):468-75. PubMed ID: 18534556 [TBL] [Abstract][Full Text] [Related]
12. Supraphysiologic doses of levothyroxine as adjunctive therapy in bipolar depression: a randomized, double-blind, placebo-controlled study. Stamm TJ; Lewitzka U; Sauer C; Pilhatsch M; Smolka MN; Koeberle U; Adli M; Ricken R; Scherk H; Frye MA; Juckel G; Assion HJ; Gitlin M; Whybrow PC; Bauer M J Clin Psychiatry; 2014 Feb; 75(2):162-8. PubMed ID: 24345793 [TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M; J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369 [TBL] [Abstract][Full Text] [Related]
14. Lamotrigine: a depression mood stabiliser. Herman E Eur Neuropsychopharmacol; 2004 May; 14 Suppl 2():S89-93. PubMed ID: 15142613 [TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH; J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366 [TBL] [Abstract][Full Text] [Related]
16. SAMe versus placebo: a double blind comparison in major depressive disorders. Muscettola G; Galzenati M; Balbi A Adv Biochem Psychopharmacol; 1982; 32():151-6. PubMed ID: 7046362 [No Abstract] [Full Text] [Related]
17. Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder. Weiser M; Burshtein S; Gershon AA; Marian G; Vlad N; Grecu IG; Tocari E; Tiugan A; Hotineanu M; Davis JM Bipolar Disord; 2014 Jun; 16(4):441-7. PubMed ID: 24712840 [TBL] [Abstract][Full Text] [Related]
18. [Clinical trial of dimethacrine]. Melo I Rev Med Suisse Romande; 1971 Mar; 91(3):183-94. PubMed ID: 5092364 [No Abstract] [Full Text] [Related]
19. Inositol augmentation of lithium or valproate for bipolar depression. Eden Evins A; Demopulos C; Yovel I; Culhane M; Ogutha J; Grandin LD; Nierenberg AA; Sachs GS Bipolar Disord; 2006 Apr; 8(2):168-74. PubMed ID: 16542187 [TBL] [Abstract][Full Text] [Related]